American Healthcare REIT, Inc. $AHR Stock Position Boosted by Bahl & Gaynor LLC

Bahl & Gaynor LLC grew its position in shares of American Healthcare REIT, Inc. (NYSE:AHR) by 3.5% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,387,684 shares of the company’s stock after purchasing an additional 46,730 shares during the quarter. Bahl & Gaynor LLC’s holdings in American Healthcare REIT were worth $71,133,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Outlook Capital Management LLC bought a new stake in American Healthcare REIT in the 2nd quarter worth approximately $25,000. Manning & Napier Advisors LLC purchased a new stake in American Healthcare REIT in the first quarter worth approximately $26,000. Covestor Ltd grew its position in American Healthcare REIT by 297.8% during the third quarter. Covestor Ltd now owns 720 shares of the company’s stock valued at $37,000 after acquiring an additional 539 shares during the last quarter. EverSource Wealth Advisors LLC grew its position in American Healthcare REIT by 193.2% during the first quarter. EverSource Wealth Advisors LLC now owns 1,032 shares of the company’s stock valued at $49,000 after acquiring an additional 680 shares during the last quarter. Finally, Mather Group LLC. purchased a new position in shares of American Healthcare REIT during the third quarter worth approximately $53,000. 16.68% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on AHR. UBS Group lowered their price objective on shares of American Healthcare REIT from $63.00 to $62.00 and set a “buy” rating for the company in a report on Tuesday, October 13th. Citizens Jmp upped their price objective on shares of American Healthcare REIT from $60.00 to $65.00 and gave the company a “market outperform” rating in a research note on Monday, July 27th. Truist Financial increased their target price on shares of American Healthcare REIT from $57.00 to $61.00 and gave the company a “buy” rating in a report on Friday, August 14th. KeyCorp lifted their target price on shares of American Healthcare REIT from $58.00 to $68.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 19th. Finally, Barclays lowered their price target on shares of American Healthcare REIT from $66.00 to $60.00 and set an “overweight” rating for the company in a research note on Tuesday, October 13th. Two analysts have rated the stock with a Strong Buy rating and thirteen have assigned a Buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Buy” and a consensus price target of $63.31.

American Healthcare REIT Trading Up 0.7%

Shares of AHR stock opened at $59.36 on Wednesday. The business has a 50-day moving average of $53.24 and a 200 day moving average of $51.76. The company has a debt-to-equity ratio of 0.15, a current ratio of 0.53 and a quick ratio of 0.48. American Healthcare REIT, Inc. has a 1-year low of $44.81 and a 1-year high of $59.53. The stock has a market capitalization of $12.94 billion, a PE ratio of 28.35, a P/E/G ratio of 1.40 and a beta of 0.78.

American Healthcare REIT (NYSE:AHR) last announced its quarterly earnings results on Thursday, November 5th. The company reported $0.58 EPS for the quarter, topping analysts’ consensus estimates of $0.56 by $0.02. American Healthcare REIT had a return on equity of 2.38% and a net margin of 3.61%. The business had revenue of $742.15 million for the quarter, compared to analysts’ expectations of $703.51 million. During the same period in the previous year, the firm earned $0.44 EPS. The business’s quarterly revenue was up 29.5% on a year-over-year basis. As a group, sell-side analysts anticipate that American Healthcare REIT, Inc. will post 2.25 earnings per share for the current year.

American Healthcare REIT Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, October 16th. Stockholders of record on Wednesday, September 30th were issued a $0.25 dividend. The ex-dividend date was Wednesday, September 30th. This represents a $1.00 annualized dividend and a dividend yield of 1.7%. American Healthcare REIT’s dividend payout ratio (DPR) is currently 204.08%.

Insider Activity at American Healthcare REIT

In related news, Director Scott A. Estes sold 2,500 shares of the company’s stock in a transaction on Tuesday, November 10th. The shares were sold at an average price of $59.32, for a total transaction of $148,300.00. Following the completion of the sale, the director directly owned 18,989 shares in the company, valued at $1,126,427.48. This represents a 11.63% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, EVP Mark E. Foster sold 2,000 shares of the stock in a transaction on Tuesday, September 1st. The shares were sold at an average price of $55.39, for a total transaction of $110,780.00. Following the sale, the executive vice president directly owned 51,617 shares of the company’s stock, valued at $2,859,065.63. The trade was a 3.73% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 6,000 shares of company stock worth $337,170 in the last 90 days. Company insiders own 0.75% of the company’s stock.

American Healthcare REIT Company Profile

American Healthcare REIT is a real estate investment trust focused on healthcare-related properties. Its portfolio includes senior housing and care communities, skilled nursing facilities, outpatient medical buildings, and integrated senior health campuses. The company owns and operates properties across the United States and the United Kingdom. Its facilities support a range of healthcare and senior living services, including assisted living, memory care, and post-acute care. American Healthcare REIT began trading on the New York Stock Exchange in 2024.